Epsilon M&A Deal Report - Aap Biomaterials

Transaction Multiples for the Valuation of Private Companies

Private Group led by Keensight Capital > Aap Biomaterials

Announced Date : 22 March 2016

Type : LBO (Leverage Buy Out)

Deal Value : Yes

Acquirer : Private Group led by Keensight Capital

Target: Aap Biomaterials

Target Country: Germany

Sector of activity : Health, Pharmaceuticals & Biotechnology

Business Description :

> aap Biomaterials operates in the field of the bone cement and biomater ...

No EMAT : 77753

Transaction multiples available

EV/Sales EV/Gross Profit EV/EBITDA EV/EBIT Eq/PBT P/E Price to Book
Historic
Current

: Multiple available

n.s : Multiple calculated, but not significant

Rating **

Source: Epsilon Research / EMAT

Comparable Transactions

Number of EMAT Reports : (Health, Pharmaceuticals & Biotechnology) = 1226

Example of comparable transactions on EMAT (same sub-sector):

Date Acquirer Target Country Multiples See details
23/02/2016 Recipharm Italia Mitim Italy 0
01/05/2010 Private Group led by Galia Gestion Gabilly (now Lyamtech) France 0

Source: Epsilon Research / EMAT

View Report

This report is accessible on EMAT, the reference database for private company acquisition multiples

Example of EMAT Report : click here

View Complete Report
About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

Sectors covered by our analysts

Studies & indices published by Epsilon Research Register to receive (free) publications updates

EMAT Report

Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

Subscribe to EMAT database